Foyston Gordon & Payne Inc Reduces Position in Henry Schein, Inc. (NASDAQ:HSIC)

Foyston Gordon & Payne Inc decreased its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 12.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 126,979 shares of the company's stock after selling 18,867 shares during the period. Henry Schein comprises 2.3% of Foyston Gordon & Payne Inc's portfolio, making the stock its 16th largest holding. Foyston Gordon & Payne Inc owned 0.10% of Henry Schein worth $9,257,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in HSIC. Cromwell Holdings LLC lifted its holdings in Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after acquiring an additional 170 shares during the period. Studio Investment Management LLC lifted its stake in shares of Henry Schein by 3.8% in the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company's stock valued at $341,000 after purchasing an additional 172 shares during the period. Simplify Asset Management Inc. lifted its stake in shares of Henry Schein by 5.0% in the second quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company's stock valued at $237,000 after purchasing an additional 175 shares during the period. Sequoia Financial Advisors LLC boosted its holdings in Henry Schein by 3.2% during the second quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company's stock worth $364,000 after buying an additional 176 shares in the last quarter. Finally, Huntington National Bank grew its position in Henry Schein by 16.8% during the third quarter. Huntington National Bank now owns 1,515 shares of the company's stock worth $110,000 after buying an additional 218 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Evercore ISI lifted their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a report on Tuesday, October 8th. Mizuho began coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price objective on the stock. JPMorgan Chase & Co. dropped their target price on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a report on Monday, August 12th. Barrington Research restated an "outperform" rating and set a $82.00 target price on shares of Henry Schein in a research report on Wednesday, November 6th. Finally, StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Seven investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $78.89.

Henry Schein Trading Down 0.3 %

Shares of HSIC traded down $0.25 during trading hours on Tuesday, hitting $74.73. The stock had a trading volume of 1,182,017 shares, compared to its average volume of 1,397,496. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63. The firm has a market cap of $9.32 billion, a P/E ratio of 30.47, a P/E/G ratio of 2.09 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company's fifty day simple moving average is $71.83 and its 200 day simple moving average is $69.92.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company's revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.32 EPS. Equities research analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Insider Activity at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the company's stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.14% of the company's stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.